dsm-firmenich has launched patent infringement proceedings in China against multiple Chinese entities, including a sclareol producer and a research institute, alleging unauthorized use of its patented technology for producing sclareol.

 

The company, a global innovator in nutrition, health and beauty, filed the case before the Xiong’An New District Court of Hebei Province. The petition alleges that the defendants used dsm-firmenich’s patent without authorization in the production of sclareol, a key intermediate used to make amber fragrance ingredients such as Ambrox Super.

 

dsm-firmenich is seeking court orders requiring the defendants to stop the alleged infringement and provide compensation.

 

“As a global leader in perfumery and beauty innovation, dsm-firmenich holds a robust portfolio of proprietary technologies. Our well-established intellectual property (IP) position, including patent rights and deep know-how on sclareol and related derivatives, enables us to ensure that our customers continue to benefit from our innovation, quality and expertise in amber-type fragrance ingredients”, said Amaury Roquette, Executive Vice President Perfumery & Beauty Ingredients at dsm-firmenich.

 

The company said the case forms part of its broader effort to defend its intellectual property and protect its investments in sclareol and sclareol-derived products.

 

“Given the strength of our IP position in sclareol and sclareol-derived products, we remain committed to taking all necessary legal actions to ensure that the company’s exclusive rights are respected and that its significant investments in innovation as well as our clients are protected globally”.